Wells Fargo’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-177,335
| Closed | -$62K | – | 6233 |
|
|
2016
Q3 | $62K | Sell |
177,335
-15,000
| -8% | -$5.24K | ﹤0.01% | 4964 |
|
|
2016
Q2 | $90K | Sell |
192,335
-50,612
| -21% | -$23.7K | ﹤0.01% | 4714 |
|
|
2016
Q1 | $330K | Buy |
242,947
+13,393
| +6% | +$18.2K | ﹤0.01% | 4009 |
|
|
2015
Q4 | $338K | Buy |
229,554
+81,703
| +55% | +$120K | ﹤0.01% | 4015 |
|
|
2015
Q3 | $233K | Sell |
147,851
-80,155
| -35% | -$126K | ﹤0.01% | 4238 |
|
|
2015
Q2 | $388K | Buy |
228,006
+67,555
| +42% | +$115K | ﹤0.01% | 4140 |
|
|
2015
Q1 | $223K | Buy |
160,451
+18,116
| +13% | +$25.2K | ﹤0.01% | 4240 |
|
|
2014
Q4 | $214K | Sell |
142,335
-3,103
| -2% | -$4.67K | ﹤0.01% | 4262 |
|
|
2014
Q3 | $300K | Buy |
145,438
+49,837
| +52% | +$103K | ﹤0.01% | 4096 |
|
|
2014
Q2 | $293K | Buy |
95,601
+27,430
| +40% | +$84.1K | ﹤0.01% | 4112 |
|
|
2014
Q1 | $170K | Buy |
68,171
+39,418
| +137% | +$98.3K | ﹤0.01% | 4334 |
|
|
2013
Q4 | $143K | Buy |
28,753
+25,588
| +808% | +$127K | ﹤0.01% | 4324 |
|
|
2013
Q3 | $7K | Sell |
3,165
-2,000
| -39% | -$4.42K | ﹤0.01% | 5107 |
|
|
2013
Q2 | $11K | Buy |
+5,165
| New | +$11K | ﹤0.01% | 4945 |
|